It has been almost 16 years since Childers et al 1,2
|
|
- Carol Carpenter
- 8 years ago
- Views:
Transcription
1 A Multiinstitutional Experience With Robotic-Assisted Hysterectomy With Staging for Endometrial Cancer M. Patrick Lowe, MD, Peter R. Johnson, MD, Scott A. Kamelle, MD, Saurabh Kumar, MD, Donald H. Chamberlain, MD, and Todd D. Tillmanns, MD OBJECTIVE: To report perioperative outcomes and learning curve characteristics from a multiinstitutional experience with robotic-assisted surgical staging for endometrial cancer. METHODS: A multiinstitutional robotic surgical consortium was created to evaluate the usefulness of robotics for gynecologic oncology surgery. An analysis of a multiinstitutional database of all patients who underwent robotic surgery for endometrial carcinoma between April 2003 and January 2009 was performed. Records were reviewed for demographic data and perioperative outcomes. Individual surgeon outcomes were analyzed as well in an attempt to evaluate characteristics of learning with incorporation of robotic technology. See related case report on page 369. From the Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Northwestern University, Chicago, Illinois; Gynecologic Oncology, University of Tennessee, Chattanooga, Chattanooga, Tennessee; Department of Obstetrics and Gynecology, University of Wisconsin School of Medicine and Public Health, Aurora Health Center, Milwaukee, Wisconsin; and Department of Obstetrics and Gynecology, University of Tennessee Health Science Center and West Clinic, Memphis, Tennessee. Presented at the 40th Annual Meeting on Women s Cancers, San Antonio, Texas, February 4 8, Corresponding author: M. Patrick Lowe, MD, Director of Gynecologic Oncology Robotics and Minimally Invasive Surgical Program, Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, Northwestern University, Feinberg School of Medicine, 250 East Superior Street, Suite , Chicago, IL 60611; mpatricklowe@mac.com. Financial Disclosure Dr. Lowe is a consultant for Intuitive Surgical (Sunnyvale, CA). Dr. Chamberlain is a proctor for Intuitive Surgical and OrthoBiotech (Horsham, PA). Dr. Tillmans is a speaker and consultant for Covidien (Mansfield, MA), Intuitive Surgical, OrthoBiotech (Horsham, PA), GlaxoSmithKline (Research Triangle Park, NC), and Genzyme (Cambridge, MA). The other authors did not report any potential conflicts of interest by The American College of Obstetricians and Gynecologists. Published by Lippincott Williams & Wilkins. ISSN: /09 RESULTS: Four hundred five patients were identified who underwent robotic surgery for endometrial cancer. Mean age was 62.2 years and mean body mass index was Fifty-five percent of patients reported a prior abdominal surgery. Final pathologic analysis demonstrated that 89.6% of all patients had stage I and II disease. Mean operative time was minutes. Mean estimated blood loss was 87.5 ml. Mean lymph node count was Mean hospital stay was 1.8 days. Intraoperative complications occurred in 3.5% of the patients and conversion to laparotomy occurred in 6.7%. Postoperative complications were reported in 14.6% of the patients. For the group, fewer than 10 cases were required to achieve proficiency with the procedure. CONCLUSION: Robotic technology may level the playing field between the novice and expert laparoscopist for endometrial cancer staging. Prospective trials should be undertaken to compare robotic and laparoscopic approaches to treat endometrial cancer. (Obstet Gynecol 2009;114:236 43) LEVEL OF EVIDENCE: III It has been almost 16 years since Childers et al 1,2 reported on 59 patients who underwent laparoscopic-assisted surgical staging for the treatment of endometrial cancer, concluding for the first time that laparoscopy was an alternative to traditional surgery for this disease. Since that initial publication, several articles on laparoscopy to treat endometrial cancer have been reported, and in 2005, Magrina 3 summarized these data and concluded that an open approach is an alternative to laparoscopy for early endometrial cancer. However, in that same year, a survey of members of the Society of Gynecologic Oncologists revealed that only 8% of gynecologic oncologists used laparoscopy to treat more than one half of their patients with endometrial cancer, highlighting the underuse of laparoscopy in this subspecialty despite 236 VOL. 114, NO. 2, PART 1, AUGUST 2009 OBSTETRICS & GYNECOLOGY
2 its benefits. 4 Shortly thereafter, in April 2005, the U.S. Food and Drug Administration approved the da Vinci Surgical System (Intuitive Surgical, Inc., Sunnyvale, CA) for use in gynecology and gynecologic oncology, ushering in a potentially new era of minimally invasive surgery for women with benign and malignant gynecologic disorders. Since that time, a small number of investigators have reported their initial outcomes on robotic surgery for the treatment of endometrial cancer. Although these initial results have been very promising, the data have been limited to single surgeon or single institution experiences To date, no multiinstitutional or randomized controlled trials on robotic surgery for the treatment of gynecologic malignancies has been reported. The da Vinci Surgical System is a robotic surgical platform that has applications in many surgical specialties (urology, general surgery, cardiovascular surgery, and gynecologic surgery). The advantages of the robotic surgical platform for gynecologic surgery have been previously reported by several authors These advantages potentially make it the ideal tool for performing complex oncologic procedures such as endometrial cancer staging that require delicate dissection (retroperitoneum, pelvic, and aortic node dissection) while maintaining the principles of oncologic surgery but in a minimally invasive fashion. In this article, we report perioperative outcomes and learning curve characteristics from a multiinstitutional experience with robotic-assisted surgical staging for endometrial cancer. MATERIALS AND METHODS A multiinstitutional robotic surgical consortium consisting of five board-certified gynecologist oncologists in distinct geographic regions of the United States was created to evaluate the usefulness of robotics for gynecologic surgery (benign and malignant). Regions of the United States represented included the Southeast, the Midsouth, and the Midwest. Between April 2003 and January 2009, a total of 959 patients underwent robotic surgery for benign gynecologic disorders or gynecologic malignancies by a surgeon in the research consortium. Institutional review board approval was obtained, and data were collected at each institution. For the purposes of the consortium, a multiinstitutional database in compliance with the Health Insurance Portability and Accountability Act of 1996 was then created for all patients who underwent robotic-assisted surgery between the April 2003 and January This database was retrospectively queried for all patients who underwent robotic-assisted surgical staging for endometrial cancer. Four hundred five patients were identified. Records were then reviewed for demographic data, medical conditions, prior abdominal or pelvic surgeries, and follow-up. The perioperative outcomes analyzed included operative time (skin skin), estimated blood loss (EBL), length of hospital stay, total lymph node count, conversion to laparotomy, and operative complications. Patients were selected for robotic surgery at the discretion of each surgeon, but limitations of patients eligible for robotic surgery included multiple prior abdominal surgeries with documented history of extensive abdominopelvic adhesions, evidence of disease outside the uterus, and large uterine size. Obesity was not considered as a contraindication for robotic surgery. Conversion to laparotomy was analyzed on an intent-to-treat basis. This was defined as any exploratory laparotomy required to complete the planned robotic hysterectomy and staging procedures (pelvic or aortic node dissection). This also included unsuccessful attempts at lysis of adhesions laparoscopically before docking of the robot. This did not include minilaparotomy for organ removal if the entire procedure was otherwise performed robotically. The decision to perform a lymph node dissection based on intraoperative findings rather than performing a full pelvic and paraaortic lymph node dissection on all patients with endometrial cancer was at the discretion of the surgeon, because some practice patterns varied. Thus in some patients, the surgeon omitted a lymph node dissection based on intraoperative findings or medical comorbidities. Individual surgeon outcomes were analyzed as well in an attempt to evaluate characteristics of learning and incorporation of robotic technology. Surgeons were ranked from the most to least number of robotic surgeries performed to compare trends in outcomes. The least number of robotic surgeries for endometrial cancer by a member of the research consortium was 41 and the most was 119. Individual surgeon outcomes analyzed included operative time, estimated blood loss, nodal count, conversion to laparotomy, hospital stay, and intraoperative complications. To further evaluate the learning curve, the group mean blood loss and operative time were compared with the individual surgeon s first chronological case that was within one standard deviation of the group mean for these measures. Once this chronological case was identified, the surgeon was required to duplicate this feat for five consecutive endometrial cancer staging surgeries to demonstrate reproducibility and attainment of proficiency with the procedure. This procedure enabled us to define the average number of cases that might be required until VOL. 114, NO. 2, PART 1, AUGUST 2009 Lowe et al Robotic Hysterectomy and Endometrial Cancer 237
3 a surgeon attains proficiency (which we defined as being able to maintain five consecutive cases within the group mean plus or minus one standard deviation). Because the average number of cases that caused learning based on the measures was known now, we decided to do a repeated measures analysis of variance on ranks of each surgeon s successive cases that differ by that average to evaluate any statistically significant learning effect. All members of the research consortium were among early adopters of robotic technology for use in gynecologic surgical applications in their respective regions of the country. For credentialing and training purposes, surgeons completed an online training course, a 1 2-day porcine surgical laboratory, case observations, and individual case proctoring (2 5 cases per surgeon) before receiving robotic surgical privileges at their respective institutions. The length of robotic surgical experience for all surgeons in the consortium ranged from 3 5 years for all surgeons at the time of data analysis. Prior experience with advanced laparoscopy also varied among the surgeons from no prior experience reported by one surgeon to another having served as a postgraduate instructor on advanced laparoscopy at Society for Gynecologic Oncologists annual meetings. All surgeons were wellversed in the technique of traditional surgery for endometrial cancer staging. Practice patterns varied among the members from private practice to university-affiliated private practice to university-affiliated academic practice. All endometrial cancer staging surgeries hysterectomies for were performed with either the da Vinci S or da Vinci Standard Surgical System. For the statistical analysis we used Kruskal-Wallis one-way analysis of variance on ranks, which was performed on individual surgeon outcomes, followed by Dunn s pair-wise multiple comparison procedure to isolate group(s) that statistically differ from the other groups. RESULTS From a database of 959 patients who underwent robotic surgery for gynecologic diseases (benign and malignant), a total of 405 patients were identified who underwent a robotic-assisted hysterectomy with staging for endometrial cancer. With regard to patient demographics, the mean age was 62.2 years. The mean body mass index was 32.4 The majority of the patients were white (90%). African American and Indian accounted for 7.73% and 1.36% of patients, respectively. The remaining patients were Hispanic. Medical comorbidities such as hypertension (62.6%) and diabetes mellitus (25.4%) were prevalent among the study group. More than one half (55%) of the patients reported a prior abdominal surgery. Three fourths (78%) of the patients had at least one of these comorbidities. Final pathologic analysis demonstrated that stage I and II disease comprised 82.8% and 6.8% of patients, respectively. Stage III disease accounted for 6.8% of the patients. No patients with Stage IV disease were identified. A total of 97% of all patients had staging information available for analysis. With regard to operative findings (Table 1), the mean operative time was minutes. The mean estimated blood loss was 87.5 ml. The mean lymph node count was Overall, 91.6% of all patients underwent at least a pelvic node dissection, and 72% underwent a pelvic and aortic lymph node dissection. The mean hospital stay was 1.8 days. Conversion from robotics to an open approach occurred in 6.7% of patients. The most common reason for conversion was associated with endometrial cancer staging (grossly involved adnexal or nodal disease, 1.5%) or uterine size greater than anticipated (2.5%). Conversion due to an inability to ventilate the patient (rising CO 2 or crepitus) occurred in only 1.5% of patients. Intraoperative complications were uncommon and occurred in only 3.5% of the patients. Intraoperative vascular injuries were rare, occurring in 1.2% of patients (Table 2). All were venous in nature and occurred during lymph node dissection. The most common venous injury was to the external iliac vein. All venous injuries were controlled with pressure, vascular clips, or FloSeal (Baxter Healthcare, Deerfield, IL) and did not require conversion to laparotomy. Postoperative complications occurred in 14.6% of Table 1. Overall Operative Findings (N 405) Mean SD SEM Confidence Interval Median Range 25% 75% Operative time Blood loss Hospital stay Node count node count Paraaortic node count SD, standard deviation; SEM, standard error of the mean. 238 Lowe et al Robotic Hysterectomy and Endometrial Cancer OBSTETRICS & GYNECOLOGY
4 Table 2. Intraoperative Complications Complication n 14 (3.5%) Vascular injury 5 Bowel injury 4 Cystotomy 3 Trocar injury 1 Pneumothorax 1 Ureteral injury 0 Rate convert to open (%) 6.7 Uterine size 10 Staging (metastasis) 6 Bowel adhesions 4 Inability to ventilate 4 adhesions 3 Hemorrhage 0 Data are n except where otherwise indicated. the patients with urinary tract infection (1.7%), deep vein thrombosis or pulmonary embolism (1.7%), pelvic abscess (1.5%), wound seroma (1.7%), lymphedema (1.2%), and postoperative fever (2.5%) reported as most common. There were two postoperative deaths (0.5%) reported in the database (Table 3). The first patient presented 3 days after surgery and 2 days after discharge from the hospital, arriving at the emergency room with abdominal pain, nausea, and vomiting. A moderate amount of ascites was noted, as well as leakage from the right external iliac artery (suspected delayed thermal injury) on imaging. A vascular stent was successfully placed. However, within 24 hours the patient s condition worsened, resulting in death from cardiopulmonary arrest. The second patient postoperatively experienced the acute onset of shortness of breath, dizziness with ambulation, and abnormal EKG changes. The patient experienced sudden Table 3. Postoperative Complications Complication n 59 (14.6%) Fever 10 Urinary tract infection 7 Venous thromboembolism 7 Wound seroma 7 Abscess 6 Lymphedema/lymphocyst 5 Vaginal cuff bleed 3 Vaginal cuff separation 3 Ileus 3 Vesicovaginal fistula 2 Death 2 Vascular injury 1 Acute renal failure 1 Retroperitoneal bleed 1 Superficial thrombosis 1 Pneumonia 0 loss of consciousness with cardiac arrest and could not be resuscitated. Individual surgeon outcomes were also analyzed for perioperative outcomes and total number of robotic surgeries. Tables 4 and 5 detail the perioperative outcomes of each surgeon with regard to operative time, blood loss, nodal yield, conversion to laparotomy, hospital stay, and intraoperative complications. In general, perioperative outcomes were similar among surgeons for estimated blood loss (range ml), nodal yield ( ), conversion to laparotomy ( %), hospital stay (range days), and intraoperative complications (range %). The differences in the median values of operative time among the surgeons is greater than would be expected by chance; there is a statistically significant difference (P.001). To isolate the group or groups that differ from the others we used a multiple comparison procedure (Dunn s method) and found that at least two surgeons were significantly different from the others (P.05). There did not seem to be an association with improved perioperative outcomes based on prior laparoscopic surgical experience (Surgeon A compared with Surgeon C) (Table 4). To further evaluate characteristics of learning, the group mean blood loss and operative time were compared with the individual surgeon s first chronological case that was within one standard deviation of the group mean for these measures. Once this chronological case was identified, the surgeon was required to duplicate this feat for five consecutive endometrial cancer staging surgeries to demonstrate proficiency. The learning curve for each surgeon and the group was calculated and is shown in Table 6. Four of the five surgeons reached the group mean estimated blood loss within their first five surgeries. Three of the five surgeons reached the group mean operative time within their first five surgeries. It should be noted in Table 6, surgeons A and B learned robotics together, surgeon C alone, and surgeons D and E learned robotics together. Thus, it seems that robotic proficiency can be achieved alone or with a surgical partner with similar outcomes. DISCUSSION The concept of minimally invasive surgery for gynecologic malignancies, such as endometrial and cervical cancer, has gone from a perceived near impossibility to a fully recognized option for many patients over the past 5 10 years. 15 The goal of minimally invasive surgery is to duplicate tradi- VOL. 114, NO. 2, PART 1, AUGUST 2009 Lowe et al Robotic Hysterectomy and Endometrial Cancer 239
5 Table 4. Summary of Operative Outcomes by Surgeon Surgeon (n cases) Median OR Time (min) Median EBL (ml) Lymph Nodes (Mean SD) CTL (%) Hospital Stay (d) Intraoperative Complication (%) A* (n 119) B(n 105) C (n 91) D(n 49) E(n 41) OR, operating room; EBL, estimated blood loss; CTL, conversion to laparotomy. * No prior advanced laparoscopic experience. Society for Gynecologic Oncologists laparoscopy instructor. tional open procedures with several small incisions in the skin, with surgical outcomes equivalent or superior to a traditional surgical approach. Despite its benefits, a laparoscopic approach has not been widely used to treat endometrial cancer by the majority of gynecologic oncologists in the United States. 4 Recently, robotic surgery has become an option in the definitive surgical management of early stage endometrial cancer The data in this multiinstitutional study were collected from the onset of each author s robotic program. It contains all robotic procedures performed by the authors to date. The strength of our study is that it allows for analysis and evaluation of data from multiple institutions with surgeons of various levels of experience and expertise with robotic surgery. Finally, each author had performed more than 50 robotic surgeries at the time of data analysis, providing an opportunity to evaluate characteristics of learning. The weakness of our study is in its retrospective nature and the lack of a comparison group. A review by Magrina 3 of the literature on laparoscopic hysterectomy with staging for endometrial cancer demonstrated that the procedure is also safe and feasible, but is associated with an operative time range of minutes, an estimated blood loss of ml, a nodal yield ranging from , a hospital stay ranging from days, and an overall complication rate of 0 25% (Boike G, Lurain J, Burke J. A comparison of laparoscopic management of endometrial cancer with traditional laparotomy [abstract]. Gynecol Oncol 1994;52:105). 1 3,16 21 The data reviewed by Magrina compare favorably to the data presented in this study, but with a longer hospital stay and greater blood loss. A review of the interim results of the Lap-2 trial (a randomized control trial comparing laparoscopy to laparotomy for the treatment of endometrial cancer) laparoscopy arm demonstrated an operative time of 203 minutes, a 23% conversion rate to open, and a hospital stay approaching 3 days, with intraoperative and postoperative complications reported in 9.5% and 22% of patients, respectively (Walker J, Peidmont M, Spirtos N, Eisenkop S, Schlaerth J, Mannel R, et al. Surgical staging of uterine cancer: randomized phase III trial of laparoscopy compared with laparotomy a Gynecologic Oncology Group Study [GOG]: preliminary results [abstract]. Proceedings of the 2006 Annual Meeting of the American Society of Clinical Oncology, Atlanta, Georgia June 2 6, 2006). When compared with the data in our series, robotic surgery seems at least equivalent if not superior to laparoscopy in several perioperative outcomes. Other investigators have also observed this conclusion in direct comparisons. 8 9,12 When compared with traditional open surgery for endometrial cancer, a robotic surgical approach has 240 Lowe et al Robotic Hysterectomy and Endometrial Cancer OBSTETRICS & GYNECOLOGY
6 Table 5. Statistical Analysis of Individual Surgeon Outcomes Surgeon (n cases) Operative Time (min) EBL (ml) Hospital Stay (d) Age (y) BMI (kg/m 2 ) Surgeon A* (n 119) Mean SD SEM CI of mean Median (range) 92.0 (606.0) 22.5 (500.0) 1.0 (4.0) 62.0 (72.0) 31.8 (35.9) 25th % th % Surgeon B (n 105) Mean SD SEM CI of mean Median (range) (250.0) 50.0 (490.0) 1.0 (17.0) 61.0 (52.0) 34.0 (39.0) 25th % th % Surgeon C (n 91) Mean SD SEM CI of Mean Median (range) (205.0) 50.0 (200.0) 1.0 (1.0) 61.0 (53.0) 30.0 (39.0) 25th % th % Surgeon D (n 49) Mean SD SEM CI of mean Median (range) (289.0) (780.0) 2.0 (29.0) 64.0 (50.0) 29.4 (41.7) 25th % th % Surgeon E (n 41) Mean SD SEM CI of mean Median (range) (232.0) (550.0) 1.0 (8.0) 63.0 (44.0) 26.0 (36.0) 25th % th % EBL, estimated blood loss; BMI, body mass index; SD, standard deviation; SEM, standard error of the mean; CI, confidence interval. * No prior advanced laparoscopic experience. Society for Gynecologic Oncologists laparoscopy instructor. demonstrated an improvement in perioperative outcomes with the exception of operative time. 8 10,12 A summary of perioperative outcomes for robotic surgical management of endometrial cancer is shown in Table 7. Although these articles primarily represent single institution or single surgeon experiences, the data are very promising and would suggest that a robotic approach is preferable to an open approach and possibly a laparoscopic approach. As with any new surgical technology the learning curve and cost are of paramount concerns. To date, four articles (including this one) have reported on various learning curves for robotic hysterectomy for benign and malignant gynecologic disease. 11,13,22 There are two articles that report the learning curve for hysterectomy with pelvic paraaortic node dissection for endometrial cancer staging. In the Ohio State experience reported by Seamon et al, 11 the number of cases to gain proficiency was reported as approximately 20 cases. In our study, we chose to determine the group mean operative time and blood loss for all cases and then defined the learning curve as the individual surgeon s first chronological case that was within one standard deviation of the group mean for these measures that was then duplicated for five consecutive endometrial cancer staging surgeries. This process confirmed reproducibility and attainment of proficiency, which in our study were nine cases for operative time and four cases for estimated blood loss. Thus, it is likely that the learning curve for robotic hysterectomy with pelvic and aortic node dissection lies between nine and 20 cases. With regard to costs, there has been one article to date comparing robotic, open, and laparoscopic procedures to surgi- VOL. 114, NO. 2, PART 1, AUGUST 2009 Lowe et al Robotic Hysterectomy and Endometrial Cancer 241
7 Table 6. Learning Curve Comparison of da Vinci Hysterectomy Plus Staging for Group Mean Estimated Blood Loss and Operative Time Compared With the Individual Physician s First Chronological Case That Was Within 1 Standard Deviation of the Group Mean and Maintained for the Following Five Cases Physician (n DHS) DHS no. of Cases to Reach Group Mean EBL (96 111) DHS no. of Cases to Reach Group Mean Operative Time(170 71) A* (n 91) 1 1 B(n 41) 4 1 C (n 119) 1 5 D(n 105) 2 19 E(n 49) (n 405) 4 9 DHS, da Vinci hysterectomy plus staging; EBL, estimated blood loss. * No prior advanced laparoscopic experience. Society for Gynecologic Oncologists laparoscopy instructor. cally stage endometrial cancer. In that report, the cost of the robotic system was included in the cost analysis for robotic surgery. The total average cost (in U.S. dollars) for hysterectomy with staging for endometrial cancer was reported as follows: open $12,943.60, laparoscopic $ , and robotic $ Interestingly, there was no statistically significant difference in costs between robotic and laparoscopic approach (P.06). Both minimally invasive approaches cost significantly less than an open approach (P.001). However, robotics was associated with less perioperative morbidity and quicker return to normal activity. 9 One unique aspect of our experience with robotic surgery for endometrial cancer is the varying degrees of prior laparoscopic experience among our surgeons before they adopted robotics into their practices. This experience ranged from the novice (no prior advanced laparoscopic experience) to the expert (Society for Gynecologic Oncologists instructor on advanced laparoscopic techniques). Interestingly, our data from this study suggest that robotic technology may level the playing field between the novice and expert minimally invasive surgeon when applied to complex operations such as endometrial cancer staging. We have identified and reported similar findings for robotic-assisted radical hysterectomy for early stage cervical cancer. 23 This conclusion is supported by the fact that several perioperative outcomes were similar among the individual surgeons irrespective of total number of robotic surgeries performed, with the exception of operative time (Table 4). This conclusion is further supported by the learning characteristics recorded during our analysis of individual surgeon outcomes as compared with overall group means for operative time and blood loss. We found no difference in the attainment of proficiency of robotic technology between the novice and expert laparoscopist (Table 6). Based on these data, the authors feel confident that a strong background in laparoscopy is not a requirement to becoming a successful robotic surgeon. A more detailed learning curve analysis will be presented in a separate article (Table 5). In conclusion, the data reported in this large, multiinstitutional study further defines the literature on robotic surgery for endometrial cancer and establishes its role as a surgical option for the treatment of endometrial cancer. Robotics has the potential to dramatically expand the minimally invasive surgical option for women undergoing surgery for endometrial cancer. Although improved perioperative outcomes have been associated with a robotic approach to treat endometrial cancer, long-term follow-up data are not available regarding recurrence rates and overall survival These data will be critical and necessary to fully define the role of robotics to treat endometrial or cervical cancers. Although robotics represents a technologic leap over traditional laparoscopy and offers the potential to redefine how gynecologic oncologists consider surgical options for their Table 7. Perioperative Outcomes for Robotic Surgical Management of Endometrial Cancer n Age (y) BMI OP Time (min) EBL (ml) LOS (d) CTL (%) LN (n) Intraoperative Complications (%) Postoperative Complications (%) Current study Seamon et al Boggess et al Hoekstra et al Denardis et al Bell et al Veljovich et al NA 17.5 BMI, body mass index; OP, operative; EBL, estimated blood loss; LOS, length of stay; CTL, conversion to laparotomy; LN, lymph nodes. 242 Lowe et al Robotic Hysterectomy and Endometrial Cancer OBSTETRICS & GYNECOLOGY
8 patients with endometrial cancer, further study in a prospective fashion should be performed. REFERENCES 1. Childers J, Brzechffa P, Hatch K, Surwit E. Laparoscopically assisted surgical staging (LASS) of endometrial cancer. Gynecol Oncol 1993;51: Childers J, Surwit E. Combined laparoscopic and vaginal surgery for the management of two cases of stage I endometrial cancer. Gynecol Oncol 1992;45: Magrina J. Outcomes of laparoscopic treatment for endometrial cancer. Curr Opin Obstet Gynecol 2005;17: Naumann RW, Coleman RL. The use of adjuvant radiation therapy in early endometrial cancer by members of the Society of Gynecologic Oncologists in Gynecol Oncol 2007;105: Reynolds R, Burke W, Advincula A. Preliminary experience with robot-assisted laparoscopic staging of gynecologic malignancies. JSLS 2005;9: Tillmanns T, Lowe MP. Update on minimally invasive surgery on the management of gynecologic malignancies: focus on robotic laparoscopic systems. Community Oncol 2007;4: Veljovich D, Paley P, Drescher C, Everett E, Shah C, Peters W. Robotic surgery in gynecologic oncology: program initiation and outcomes after the first year with comparison with laparotomy for endometrial cancer staging. Am J Obstet Gynecol 2008;198:679.e Boggess J, Gehrig P, Cantrell L, Shafer A, Ridgway M, Skinner E, et al. A comparative study of 3 surgical methods for hysterectomy with staging for endometrial cancer: robotic assistance, laparoscopy, laparotomy. Am J Obstet Gynecol 2008;199:360e Bell MC, Torgerson J, Seshadri-Kreaden U, Suttle AW, Hunt S. Comparison of outcomes and cost for endometrial cancer staging via traditional laparotomy, standard laparoscopy, and robotic technique. Gynecol Oncol 2008;111: DeNardis SA, Holloway RW, Bigsby GE 4th, Pikaart DP, Ahmad S, Finkler NJ. Robotically assisted laparoscopic hysterectomy versus total abdominal hysterectomy and lymphadenectomy for endometrial cancer. Gynecol Oncol 2008;111: Seamon LG, Cohn DE, Richardson DL, Valmadre S, Carlson MJ, Phillips GS, et al. Robotic hysterectomy and pelvic-aortic lymphadenectomy for endometrial cancer. Obstet Gynecol 2008;112: Hoekstra AV, Jairam-Thodla A, Rademaker A, Singh DK, Buttin BM, Lurain JR, et al. The impact of robotics on practice management of endometrial cancer: transitioning from traditional surgery. Int J Med Robot 2009 May 19. [Epub ahead of print]. 13. Kho R, Hilger W, Hentz J, Magtibay P, Magrina J. Robotic hysterectomy: technique and initial outcomes [published erratum appears in Am J Obstet Gynecol 2007;197:332]. Am J Obstet Gynecol 2007;197:113.e Jairam-Thodla A, Hoekstra AV, Lowe MP. A comparison of post-operative analgesic use in 3 different surgical staging modalities for early stage endometrial cancer. J Minim Invasive Gynecol 2008;15:38s. 15. Lowe MP, Bahador A, Muderspach LI, Burnett A, Santos L, Caffrey A, et al. Feasibility of laparoscopic extraperitoneal surgical staging for locally advanced cervical carcinoma in a gynecologic oncology fellowship training program. J Minim Invasive Gynecol 2006;13: Spirtos N, Schlaerth J, Gross G, Spirtos T, Schlaerth A, Ballon S. Cost and quality-of-life analyses of surgery for early endometrial cancer: laparotomy versus laparoscopy. Am J Obstet Gynecol 1996;174: Magrina J, Mutone N, Weaver A, Magtibay P, Fowler R, Cornella J. Laparoscopic lymphadenectomy and vaginal or laparoscopic hysterectomy with bilateral salpingo-oophorectomy for endometrial cancer: morbidity and survival. Am J Obstet Gynecol 1999;181: Gemignani M, Curtin J, Zelmanovich J, Patel D, Venkatraman E, Barakat R. Laparoscopic-assisted vaginal hysterectomy for endometrial cancer: clinical outcomes and hospital charges. Gynecol Oncol 1999;73: Scribner D, Walker J, Johnson G, McMeekin S, Gold M, Mannel R. Surgical management of early-stage endometrial cancer in the elderly: is laparoscopy feasible? Gynecol Oncol 2001;83: Eltabbakh GH. Analysis of survival after laparoscopy in women with endometrial carcinoma. Cancer 2002;95: Tozzi R, Malur S, Koehler C, Schneider A. Laparoscopy versus laparotomy in endometrial cancer: first analysis of survival of a randomized prospective study. J Minim Invasive Gynecol 2005;12: Payne TN, Dauterive FR. A comparison of total laparoscopic hysterectomy to robotically assisted hysterectomy: surgical outcomes in a community practice. J Minim Invasive Gynecol 2008;15: Lowe MP, Chamberlain DH, Kamelle SA, Johnson PR, Tillmanns TD. A multi-institutional experience with roboticassisted radical hysterectomy for early stage cervical cancer. Gynecol Oncol 2009;113: VOL. 114, NO. 2, PART 1, AUGUST 2009 Lowe et al Robotic Hysterectomy and Endometrial Cancer 243
DA VINCI ROBOTIC HYSTERECTOMY
DA VINCI ROBOTIC HYSTERECTOMY Until recently, surgery for most gynecologic conditions was performed using a large abdominal incision. This is because while conventional laparoscopic surgery is effective
More informationFacing a Hysterectomy? If you ve been diagnosed with early stage gynecologic cancer, learn about minimally invasive da Vinci Surgery
Facing a Hysterectomy? If you ve been diagnosed with early stage gynecologic cancer, learn about minimally invasive da Vinci Surgery The Condition: Early Stage Gynecologic Cancer A variety of gynecologic
More informationINTERVENTIONAL PROCEDURES PROGRAMME
NATIONAL INSTITUTE FOR CLINICAL EXCELLENCE INTERVENTIONAL PROCEDURES PROGRAMME Interventional procedure overview of radical laparoscopic hysterectomy for early stage cervical cancer Introduction This overview
More informationSumma Health System. A Woman s Guide to Hysterectomy
Summa Health System A Woman s Guide to Hysterectomy Hysterectomy A hysterectomy is a surgical procedure to remove a woman s uterus (womb). The uterus is the organ which shelters and nourishes a baby during
More informationRESEARCH ARTICLE. Abstract. Introduction. Materials and Methods
DOI:http://dx.doi.org/10.7314/APJCP.2015.16.13.5483 Perioperative and Oncologic Outcomes with Laparotomy, and Laparoscopic, and Robotic Surgery for Endometrial Cancer RESEARCH ARTICLE Comparison of Perioperative
More informationReview Article Robot-Assisted Radical Hysterectomy for Cervical Cancer: Review of Surgical and Oncological Outcomes
International Scholarly Research Network ISRN Obstetrics and Gynecology Volume 2011, Article ID 872434, 6 pages doi:10.5402/2011/872434 Review Article Robot-Assisted Radical Hysterectomy for Cervical Cancer:
More informationRadical Hysterectomy for Early Stage Cervical Cancer: Laparoscopy Versus Laparotomy
SCIENTIFIC PAPER Radical Hysterectomy for Early Stage Cervical Cancer: Laparoscopy Versus Laparotomy Sarah E. Taylor, MD, William C. McBee Jr., MD, Scott D. Richard, MD, Robert P. Edwards, MD ABSTRACT
More informationThe Role of Laparoscopy in Endometrial Cancer
The Role of Laparoscopy in Endometrial Cancer Prof. Dr. Tugan BEŞE İstanbul University, Cerrahpaşa Medical Faculty Gynecologic Oncology Department Surgical staging in Endometrial Cancer Laparoscopic surgery
More informationLaparoscopic treatment of endometrial cancer: feasibility and results
European Journal of Obstetrics & Gynecology and Reproductive Biology 124 (2006) 232 236 www.elsevier.com/locate/ejogrb Laparoscopic treatment of endometrial cancer: feasibility and results Eugenio Volpi,
More informationHow To Perform Da Vinci Surgery
Facing a Hysterectomy? If you ve been diagnosed with early stage gynecologic cancer, learn about minimally invasive da Vinci Surgery The Condition: Early Stage Gynecologic Cancer A variety of gynecologic
More informationRole of Robotic Surgery in Obese Women with Endometrial Cancer
Role of Robotic Surgery in Obese Women with Endometrial Cancer Anil Tailor Consultant Gynaecological Oncologist Royal Surrey County Hospital Guildford, Surrey, UK St Peters Hospital Chertsey, Surrey, UK
More informationRobotic versus total laparoscopic radical hysterectomy with pelvic lymphadenectomy for the treatment of early cervical cancer
International Journal of Reproduction, Contraception, Obstetrics and Gynecology Goud JG et al. Int J Reprod Contracept Obstet Gynecol. 2014 Mar;3(1):34-39 www.ijrcog.org pissn 2320-1770 eissn 2320-1789
More informationClinical Practice Assessment Robotic surgery
Clinical Practice Assessment Robotic surgery Background: Surgery is by nature invasive. Efforts have been made over time to reduce complications and the trauma inherently associated with surgery through
More informationLaparoscopic hysterectomy with or without pelvic. lymphadenectomy or sampling in a high-risk series of
Laparoscopic hysterectomy with or without pelvic lymphadenectomy or sampling in a high-risk series of patients with endometrial cancer Susan F Willis Thomas EJ Ind * Desmond Barton Department of Gynaecological
More informationHysterectomy. What is a hysterectomy? Why is hysterectomy done? Are there alternatives to hysterectomy?
ROBERT LEVITT, MD JESSICA BERGER-WEISS, MD ADRIENNE POTTS, MD HARTAJ POWELL, MD, MPH COURTNEY LEVENSON, MD LAUREN BURNS, MSN, RN, WHNP OBGYNCWC.COM What is a hysterectomy? Hysterectomy Hysterectomy is
More informationRobotic-Assisted Surgery in Gynecological Oncology
The use of robotic-assisted surgery is rapidly expanding into the field of gynecological oncology. Sofía Cáceres Nazario. Red Dahlia, 2015 (Detail). Acrylic on canvas, 16" 12". Robotic-Assisted Surgery
More informationTotal laparoscopic hysterectomy for endometrial cancer: patterns of recurrence and survival
Gynecologic Oncology 92 (2004) 789 793 www.elsevier.com/locate/ygyno Total laparoscopic hysterectomy for endometrial cancer: patterns of recurrence and survival Andreas Obermair, a,b, * Tom P. Manolitsas,
More informationSurgical Staging of Endometrial Cancer
Surgical Staging of Endometrial Cancer I. Endometrial Cancer Surgical Staging Overview Uterine cancer types: carcinomas type I and type II, sarcomas, carcinosarcomas Hysterectomy with BSO Surgical Staging
More informationPerioperative Outcomes in Robotic-Assisted Versus Conventional Laparoscopic Treatment of Endometrial Cancer
Research Article imedpub Journals http://www.imedpub.com/ Journal of Adenocarcinoma 206 Vol. No. :6 Perioperative Outcomes in Robotic-Assisted Versus Conventional Laparoscopic Treatment of Endometrial
More informationMINIMALLY INVASIVE SURGERY FOR WOMEN Back to Life. Faster.
MINIMALLY INVASIVE SURGERY FOR WOMEN Back to Life. Faster. Pictured above: UF gynecologists Sharon Byun, MD, Shireen Madani Sims, MD, and Michael Lukowski, MD, with the robotic surgery equipment. Make
More informationConsidering a Hysterectomy?
Considering a Hysterectomy? Learn more about virtually scarless surgery using da Vinci Single-Site technology { {Symptoms & Conditions: Chronic Pain, Heavy Bleeding, Fibroids, Endometriosis, Adenomyosis,
More information2 Laparoscopic hysterectomy in endometrial cancer
Laparoscopic hysterectomy in endometrial cancer .1 Total laparoscopic hysterectomy versus abdominal hysterectomy in the treatment of patients with early stage endometrial cancer: A randomized multi center
More informationConsidering Endometriosis Surgery? Learn about minimally invasive da Vinci Surgery
Considering Endometriosis Surgery? Learn about minimally invasive da Vinci Surgery The Condition: Endometriosis Endometriosis is a condition in which the tissue that lines your uterus (the endometrium)
More informationHysterectomy. The time to take care of yourself
Hysterectomy The time to take care of yourself The time to take care of yourself Women spend a lot of time taking care of others spouses, children, parents. We often overlook our own needs. But when our
More informationUnderstanding Your Diagnosis of Endometrial Cancer A STEP-BY-STEP GUIDE
Understanding Your Diagnosis of Endometrial Cancer A STEP-BY-STEP GUIDE Introduction This guide is designed to help you clarify and understand the decisions that need to be made about your care for the
More informationHow To Compare The Effects Of A Hysterectomy And A Hysterectomy
A RANDOMIZED TRIAL COMPARING RADICAL HYSTERECTOMY AND PELVIC NODE DISSECTION VS SIMPLE HYSTERECTOMY AND PELVIC NODE DISSECTION IN PATIENTS WITH LOW RISK EARLY STAGE CERVICAL CANCER A Gynecologic Cancer
More informationFacing Pancreatic Surgery? Learn about minimally invasive da Vinci Surgery
Facing Pancreatic Surgery? Learn about minimally invasive da Vinci Surgery The Condition: Pancreatitis/Pancreatic Cancer The pancreas is an organ that produces enzymes and hormones to help your body digest
More informationThe Use of Minimally Invasive Surgery for Endometrial Cancer
Alternative approaches to traditional laparotomy such as minimally invasive surgery can diminish procedure-related morbidity and expedite recovery for patients with endometrial cancer. Marguerite Bride.
More informationStrategic Acquisition
Date: Fiscal Year 2013 To: From: Re: Hospital Executives Kathryn Barry, MPH, MSN, RN Health Policy Specialist for Intuitive Surgical Planning for Long Term Success with a Robotic Surgery Program As the
More informationDate: 06/06/2014 Our ref: 4496. I write in response to your request for information in relation to treatment for endometrial cancer in NHS Lothian.
Lothian NHS Board Waverley Gate 2-4 Waterloo Place Edinburgh EH1 3EG Telephone 0131 536 9000 Fax 0131 536 9088 www.nhslothian.scot.nhs.uk Date: 06/06/2014 Our ref: 4496 Enquiries to: Bryony Pillath Extension:
More informationConsidering Surgery for Fibroids? Learn about minimally invasive da Vinci Surgery
Considering Surgery for Fibroids? Learn about minimally invasive da Vinci Surgery The Condition: Uterine Fibroid (Fibroid Tumor) A uterine fibroid is a benign (non-cancerous) tumor that grows in the uterine
More informationSentinel Lymph Node Mapping for Endometrial Cancer. Locke Uppendahl, MD Grand Rounds
Sentinel Lymph Node Mapping for Endometrial Cancer Locke Uppendahl, MD Grand Rounds Endometrial Cancer Most common gynecologic malignancy in US estimated 52,630 new cases in 2014 estimated 8,590 deaths
More informationLaparoscopy versus Laparotomy for primary surgical management of endometrial cancer
Laparoscopy versus Laparotomy for primary surgical management of endometrial cancer Dr. Maria Anna Sabelli Consultant Gynecologist Milano Italy P.O. Box 20154 Milano Milano 20154 Italy Project submitted
More informationConsidering a Hysterectomy?
Considering a Hysterectomy? Learn more about virtually scarless surgery using da Vinci Single-Site technology { {Symptoms & Conditions: Chronic Pain, Heavy Bleeding, Fibroids, Endometriosis, Pelvic Prolapse
More informationHow To Treat A Uterine Sarcoma
EVERYONE S GUIDE FOR CANCER THERAPY Malin Dollinger, MD, Ernest H. Rosenbaum, MD, Margaret Tempero, MD, and Sean Mulvihill, MD 4 th Edition 2001 Uterus: Uterine Sarcomas Jeffrey L. Stern, MD Uterine sarcomas
More informationLaparoscopic Repair of Incisional Hernia. Maria B. ALBUJA-CRUZ, MD University of Colorado Department of Surgery-Grand Rounds
Laparoscopic Repair of Incisional Hernia Maria B. ALBUJA-CRUZ, MD University of Colorado Department of Surgery-Grand Rounds Overview Definition Advantages of Laparoscopic Repair Disadvantages of Open Repair
More informationJ Clin Oncol 30:783-791. 2012 by American Society of Clinical Oncology INTRODUCTION
VOLUME 30 NUMBER 8 MARCH 10 2012 JOURNAL OF CLINICAL ONCOLOGY O R I G I N A L R E P O R T Comparative Effectiveness of Robotic Versus Laparoscopic Hysterectomy for Endometrial Cancer Jason D. Wright, William
More informationPhysician. Patient HYSTERECTOMY HYSTERECTOMY. Treatment Options Risks and Benefits Experience and Skill
HYSTERECTOMY Physician Treatment Options Risks and Benefits Experience and Skill Patient Personal Preferences Values and Concerns Lifestyle Choices HYSTERECTOMY Shared Decision Making A process of open
More informationTotal Laparoscopic Hysterectomy Versus Total Abdominal Hysterectomy for Endometrial Cancer: A Meta-analysis
DOI:http://dx.doi.org/0.734/APJCP.203.4.4.255 RESEARCH ARTICLE Total Laparoscopic Hysterectomy Versus Total Abdominal Hysterectomy for Endometrial Cancer: A Meta-analysis Hui-Ling Wang, Yan-Fang Ren *,
More informationFacing Hysterectomy? Learn why da Vinci Surgery may be your best treatment option for early stage gynecologic cancer
Facing Hysterectomy? Learn why da Vinci Surgery may be your best treatment option for early stage gynecologic cancer The Condition: Early Stage Gynecologic Cancer A wide variety of gynecologic cancers
More informationResults of Surgery in a New Lung Institute in South Texas Focused on the Treatment of Lung Cancer
Results of Surgery in a New Lung Institute in South Texas Focused on the Treatment of Lung Cancer Lung cancer accounts for 13% of all cancer diagnoses and is the leading cause of cancer death in both males
More informationThe main surgical options for treating early stage cervical cancer are:
INFORMATION LEAFLET ON TOTAL LAPAROSCOPIC RADICAL HYSTERECTOMY (TLRH) FOR EARLY STAGE CERVICAL CANCER (TREATING EARLY STAGE CERVICAL CANCER BY RADICAL HYSTERECTOMY THROUGH KEYHOLE SURGERY) Aim of the leaflet
More informationEndoscopic Surgical Procedures for Cervical Cancer Treatment: A Literature Review
Endoscopic Surgical Procedures for Cervical Cancer Treatment: A Literature Review Andrea Tinelli, Antonio Perrone Department of Obstetrics and Gynaecology Vito Fazzi Hospital, Lecce, Italy Sarah Gustapane,
More informationLaparoscopic Assisted Vaginal Hysterectomy
Department of Obstetrics and Gynecology, Chang Gung Memorial Hospital at ChiaYi 嘉 義 長 庚 紀 念 醫 院 婦 產 科 Clinical Guideline Laparoscopic Assisted Vaginal Hysterectomy By Dr. CJ Tseng Laparoscopic assisted
More informationRe irradiation Using HDR Interstitial Brachytherapy for Locally Recurrent. Disclosure
Re irradiation Using HDR Interstitial Brachytherapy for Locally Recurrent Cervical lcancer Yasuo Yoshioka, MD Department of Radiation Oncology Osaka University Graduate School of Medicine Osaka, Japan
More informationINFORMED CONSENT FOR SLEEVE GASTRECTOMY
INFORMED CONSENT FOR SLEEVE GASTRECTOMY This informed-consent document has been prepared to help inform you about your Sleeve Gastrectomy including the risks and benefits, as well as alternative treatments.
More informationCarcinoma of the Cervix. Kathleen M. Schmeler, MD Associate Professor Department of Gynecologic Oncology
Carcinoma of the Cervix Kathleen M. Schmeler, MD Associate Professor Department of Gynecologic Oncology Cervical Cancer Treatment Treatment Microinvasive (Stage IA1): Simple (extrafascial) hysterectomy/cone
More informationAdvances in Robotic Technology
Advances in Robotic Technology Reza Ghavamian M.D. Professor of Urology Director of Urologic Oncology and Robotic Surgery Montefiore Medical Center Albert Einstein College of Medicine New York Disclosure
More informationNovaSure: A Procedure for Heavy Menstrual Bleeding
NovaSure: A Procedure for Heavy Menstrual Bleeding The one-time, five-minute procedure Over a million women 1 have been treated with NovaSure. NovaSure Endometrial Ablation (EA) is the simple, one-time,
More informationA Practical Guide to Advances in Staging and Treatment of NSCLC
A Practical Guide to Advances in Staging and Treatment of NSCLC Robert J. Korst, M.D. Director, Thoracic Surgery Medical Director, The Blumenthal Cancer Center The Valley Hospital Objectives Revised staging
More informationNo Costly Hospital Stays. No Unsightly Incisions. Far Faster, Less Painful Recovery.
No Costly Hospital Stays. No Unsightly Incisions. Far Faster, Less Painful Recovery. No Costly Hospital Stays. No Unsightly Incisions. Far Faster, Less Painful Recovery. Welcome to the Georgia Advanced
More informationda Vinci Prostatectomy Information Guide (Robotically-Assisted Radical Prostatectomy)
da Vinci Prostatectomy Information Guide (Robotically-Assisted Radical Prostatectomy) Prostate Cancer Overview Prostate cancer is a disease in which malignant (cancer) cells form in the tissues of the
More informationPreoperative Laboratory and Diagnostic Studies
Preoperative Laboratory and Diagnostic Studies Preoperative Labratorey and Diagnostic Studies The concept of standardized testing in all presurgical patients regardless of age or medical condition is no
More informationThomas A. Kollmorgen, M.D. Oregon Urology Institute
Thomas A. Kollmorgen, M.D. Oregon Urology Institute None 240,000 new diagnosis per year, and an estimated 28,100 deaths (2012) 2 nd leading cause of death from cancer in U.S.A. Approximately 1 in 6 men
More informationSURGICAL SERVICES. Touching Lives
SURGICAL SERVICES Touching Lives with MODERN TOOLS of EXPERT PHYSICIANS in the Hands and Staff FROM DISCOVERY TO RECOVERY St. Mary s Health System offers a full range of surgical services in almost every
More informationResults of streamlined regional ambulance transport and subsequent treatment of acute abdominal aortic aneurysm
CHAPTER 6 Results of streamlined regional ambulance transport and subsequent treatment of acute abdominal aortic aneurysm JW Haveman, A Karliczek, ELG Verhoeven, IFJ Tielliu, R de Vos, JH Zwaveling, JJAM
More informationImpact of Robotic Surgery in Minimally Invasive Management of Oncofertility Patients
Impact of Robotic Surgery in Minimally Invasive Management of Oncofertility Patients Farr R. Nezhat, MD, FACOG Professor of Obstetrics and Gynecology Director, Gynecologic Robotic and Minimally Invasive
More informationAdjuvant Therapy for Breast Cancer: Questions and Answers
CANCER FACTS N a t i o n a l C a n c e r I n s t i t u t e N a t i o n a l I n s t i t u t e s o f H e a l t h D e p a r t m e n t o f H e a l t h a n d H u m a n S e r v i c e s Adjuvant Therapy for Breast
More informationContributors Marjan Attaran, MD Mohamed A. Bedaiwy, MD, PhD Andrew Brill, MD Chi Chiung Grace Chen, MD Gouri B. Diwadkar, MD Richard D.
Contributors Marjan Attaran, MD Transposition Mohamed A. Bedaiwy, MD, PhD Associate Professor, Department of Obstetrics and Gynecology, Assiut School of Medicine, Assiut, Egypt, Clinical Fellow, Department
More informationGet the Facts, Be Informed, Make YOUR Best Decision. Pelvic Organ Prolapse
Pelvic Organ Prolapse ETHICON Women s Health & Urology, a division of ETHICON, INC., a Johnson & Johnson company, is dedicated to providing innovative solutions for common women s health problems and to
More information9/26/14. Joel E. Rand, MPAS, PA-C DMU Luncheon May 1, 2014
Joel E. Rand, MPAS, PA-C DMU Luncheon May 1, 2014 No financial relationship or commercial interest in any of the technologies discussed Not supporting any non-fda off label uses of any product or service
More informationThe role of vaginal hysterectomy in the treatment of endometrial carcinoma
Int J Gynecol Cancer 1994, 4, 342-347 The role of vaginal hysterectomy in the treatment of endometrial carcinoma R. J. LELLI~*, G. W. MORLEY* & W. A. PETERS ~ *Department of Obstetrics and Gynecology,
More informationRotation Specific Goals & Objectives: University Health Network-Princess Margaret Hospital/ Sunnybrook Breast/Melanoma
Rotation Specific Goals & Objectives: University Health Network-Princess Margaret Hospital/ Sunnybrook Breast/Melanoma Medical Expert: Breast Rotation Specific Competencies/Objectives 1.0 Medical History
More informationInformed Consent for Laparoscopic Vertical Sleeve Gastrectomy. Patient Name
Informed Consent for Laparoscopic Vertical Sleeve Gastrectomy Patient Name Please read this form carefully and ask about anything you may not understand. I consent to have a laparoscopic Vertical Sleeve
More informationA Checklist for Patients with Breast Cancer
A Checklist for Patients with Breast Cancer Questions to Ask the Doctor 1 and Quick Help Resources 1 Adapted from: American Cancer Society. Detailed Guide: Breast Cancer - What Should You Ask Your Doctor
More informationThe percentage of women 21-64 years of age who received one or more Pap tests to screen for cervical cancer.
Measure Name: Cervical Cancer Screen Owner: NCQA (CCS) Measure Code: CER Lab Data: Y Rule Description: General Criteria Summary The percentage of women 21-64 years of age who received one or more Pap tests
More informationPATIENT CONSENT TO PROCEDURE - ROUX-EN-Y GASTRIC BYPASS
As a patient you must be adequately informed about your condition and the recommended surgical procedure. Please read this document carefully and ask about anything you do not understand. Please initial
More informationEMPLOYMENT: Southern Pines Women s Health Center 145 Applecross Road Southern Pines, NC 28388 OB/GYN
CURRICULUM VITAE NAME: John W. Byron, M.D., F.A.C.O.G., F.A.C.S. Obstetrics and Gynecology CERTIFICATION: 2001 - present Recertification American Board of Obstetrics and Gynecology 1991 The American Board
More informationLaparoscopic Cholecystectomy
Laparoscopic Cholecystectomy Gallbladder removal is one of the most commonly performed surgical procedures in the United States. Today,gallbladder surgery is performed laparoscopically. The medical name
More informationEvolution of radical hysterectomy for cervical cancer along the last two decades: single institution experience
Original Article Evolution of radical hysterectomy for cervical cancer along the last two decades: single institution experience Claudia Arispe, Ana Isabel Pomares, Javier De Santiago, Ignacio Zapardiel
More informationClinical Policy Title: Leiomyosarcoma and Laparoscopic Power Morcellation
Clinical Policy Title: Leiomyosarcoma and Laparoscopic Power Morcellation Clinical Policy Number: 12.03.01 Effective Date: January 1, 2015 Initial Review Date: August 20, 2014 Most Recent Review Date:
More informationUrinary Diversion: Ileovesicostomy/Ileal Loop/Colon Loop
Urinary Diversion: Ileovesicostomy/Ileal Loop/Colon Loop Why do I need this surgery? A urinary diversion is a surgical procedure that is performed to allow urine to safely pass from the kidneys into a
More informationAbout the Uterus. Hysterectomy may be done to treat conditions that affect the uterus. Some reasons a hysterectomy may be needed include:
Hysterectomy removal of the uterus is a way of treating problems that affect the uterus. Many conditions can be cured with hysterectomy. Because it is major surgery, your doctor may suggest trying other
More informationConsidering Bariatric Surgery? Learn about minimally invasive da Vinci Surgery
Considering Bariatric Surgery? Learn about minimally invasive da Vinci Surgery The Condition: Obesity Obesity is defined as having a body mass index (BMI) of 30 or greater. Obesity is a serious medical
More information!"#$"%&'()*#+,'(-./0(1234()',5(!**+'%( 367361234(
THE TUMULTUOUS MARRIAGE OF MORCELLATION AND MIS; CAN OR SHOULD THIS RELATIONSHIP BE SAVED? Julian C. Schink MD Chief of Women s Health Spectrum Health Medical Group Grand Rapids, MI Disclosure! I have
More informationSection 2. Overview of Obesity, Weight Loss, and Bariatric Surgery
Section 2 Overview of Obesity, Weight Loss, and Bariatric Surgery What is Weight Loss? How does surgery help with weight loss? Short term versus long term weight loss? Conditions Improved with Weight Loss
More informationPreservation and Incorporation of Valuable Endoscopic Innovations (PIVI)
Preservation and Incorporation of Valuable Endoscopic Innovations (PIVI) The American Society for Gastrointestinal Endoscopy PIVI on Endoscopic Bariatric Procedures (short form) Please see related White
More informationFrequently Asked Questions About Ovarian Cancer
Media Contact: Gerri Gomez Howard Cell: 303-748-3933 gerri@gomezhowardgroup.com Frequently Asked Questions About Ovarian Cancer What is ovarian cancer? Ovarian cancer is a cancer that forms in tissues
More informationda Vinci Hysterectomy Changing the Experience of Surgery Are you a candidate for a breakthrough approach to hysterectomy?
da Vinci Hysterectomy Changing the Experience of Surgery Are you a candidate for a breakthrough approach to hysterectomy? Your doctor may be able to offer you a new, minimally invasive surgical procedure.
More informationLaparoscopy and Hysteroscopy
AMERICAN SOCIETY FOR REPRODUCTIVE MEDICINE Laparoscopy and Hysteroscopy A Guide for Patients PATIENT INFORMATION SERIES Published by the American Society for Reproductive Medicine under the direction of
More informationRobotic Radical Prostatectomy: What s s the Advantage? Matthew T. Gettman, M.D. Associate Professor Department of Urology
Robotic Radical Prostatectomy: What s s the Advantage? Matthew T. Gettman, M.D. Associate Professor Department of Urology Prostate Cancer Epidemiology: 2009 Estimated new cases: 230,000 Estimated deaths:
More informationTotal laparoscopic hysterectomy versus abdominal hysterectomy in the. treatment of patients with early stage endometrial cancer:
Total laparoscopic hysterectomy versus abdominal hysterectomy in the treatment of patients with early stage endometrial cancer: A randomized multi center study Claudia B.M. Bijen a, Justine M. Briët a,
More informationObesity Affects Quality of Life
Obesity Obesity is a serious health epidemic. Obesity is a condition characterized by excessive body fat, genetic and environmental factors. Obesity increases the likelihood of certain diseases and other
More informationLaparoscopic Pelvic Surgery for Endometrial Cancer
130 Laparoscopic Pelvic Surgery for Endometrial Cancer Eng-Hseon Tay Original Article Laparoscopic Pelvic Surgery for Endometrial Cancer Eng-Hseon Tay, 1 FRCOG (UK), MMed (O & G), DGO (RANZCOG) Abstract
More informationPreset ureter catheter in laparoscopic radical hysterectomy of cervical cancer
Preset ureter catheter in laparoscopic radical hysterectomy of cervical cancer L. Han 1, R. Cao 1, J.Y. Jiang 1, Y. Xi 1, X.C. Li 2 and G.H. Yu 3 1 Department of Gynecology, Dalian Obstetrics and Gynecology
More informationSawsan As-Sanie, MD, MPH University of Michigan Ann Arbor, Michigan
Sawsan As-Sanie, MD, MPH University of Michigan Ann Arbor, Michigan 2-Year Program Optional Degrees: MPH MBA MS Other: None Number of Faculty: GYN Faculty: 3 UROGYN Faculty: 5 REI Faculty: 5 ONCOLOGY Faculty:
More informationFacing Prostate Cancer Surgery? Learn about minimally invasive da Vinci Surgery
Facing Prostate Cancer Surgery? Learn about minimally invasive da Vinci Surgery The Condition: Prostate Cancer Your prostate is a walnut-sized gland that is part of the male reproductive system. The prostate
More informationBirth after previous caesarean. What are my choices for birth after a caesarean delivery?
Birth after previous caesarean Information for you Published September 2008 What are my choices for birth after a caesarean delivery? More than one in five women (20%) in the UK currently give birth by
More informationWeight Loss before Hernia Repair Surgery
Weight Loss before Hernia Repair Surgery What is an abdominal wall hernia? The abdomen (commonly called the belly) holds many of your internal organs. In the front, the abdomen is protected by a tough
More informationGruppo di lavoro: Malattie Tromboemboliche
Gruppo di lavoro: Malattie Tromboemboliche 2381 Soluble Recombinant Thrombomodulin Ameliorates Hematological Malignancy-Induced Disseminated Intravascular Coagulation More Promptly Than Conventional Anticoagulant
More informationHysterectomy for womb cancer
Gynaecology Oncology Service Hysterectomy for womb cancer April 2014 Great Staff Great Care Great Future INTRODUCTION This leaflet has been produced to provide you with general information about your operation.
More informationGuidelines for Management of Renal Cancer
Guidelines for Management of Renal Cancer Date Approved by Network Governance July 2012 Date for Review July 2015 Changes Between Versions 2 and 3 Section 5 updated bullets 5.3 and 5.4 Section 6 updated
More informationProfessional Liability Insurance Changes in Practice as a Result of the Affordability or Availability of Professional Liability Insurance
Overview of the 2015 ACOG Survey on Professional Liability By Andrea M. Carpentieri, MA, James J. Lumalcuri, MSW, Jennie Shaw, MPH, and Gerald F. Joseph, Jr., MD, FACOG The 2015 Survey on Professional
More informationSpecialists In Reproductive Medicine & Surgery, P.A.
Specialists In Reproductive Medicine & Surgery, P.A. Craig R. Sweet, M.D. www.dreamababy.com Fertility@DreamABaby.com Excellence, Experience & Ethics Endometriosis Awareness Week/Month Common Questions
More informationINTRAPERITONEAL HYPERTHERMIC CHEMOTHERAPY (IPHC) FOR PERITONEAL CARCINOMATOSIS AND MALIGNANT ASCITES. INFORMATION FOR PATIENTS AND FAMILY MEMBERS
INTRAPERITONEAL HYPERTHERMIC CHEMOTHERAPY (IPHC) FOR PERITONEAL CARCINOMATOSIS AND MALIGNANT ASCITES. INFORMATION FOR PATIENTS AND FAMILY MEMBERS Description of Treatment A major difficulty in treating
More informationEvidence tabel Lokaal palliatieve behandelingen
Auteurs, jaartal Mate van bewijs Studie type Follow-up Populatie (incl. steekproef-grootte) Patienten kenmerken Interventie Controle Resultaten Conclusie Opmerkingen, commentaar Hartgrink, 2002 The Netherlands
More informationCancer Care Delivered Locally by Physicians You Know and Trust
West Florida Physician Office Building Johnson Ave. University Pkwy. Olive Road N. Davis Hwy. For more information on West Florida Cancer Center: 850-494-5404 2130 East Johnson Avenue Pensacola, Florida
More informationWhy would you need a hysterectomy?
Why would you need a hysterectomy? Removal of the uterus is performed to prevent, alleviate, or treat pain, pressure, bleeding, or cancer. Each reason is described in detail in the following pages. Benign
More informationIs Total Laparoscopic Surgery for Endometrial Carcinoma at Risk of Local Recurrence? A Long-term Survival
Is Total Laparoscopic Surgery for Endometrial Carcinoma at Risk of Local Recurrence? A Long-term Survival RENATO SERACCHIOLI 1, STEFANO VENTUROLI 1, MICHELA CECCARINI 2, MARIANNA CANTARELLI 1, MARCELLO
More informationThe Adnexal Mass and Early Ovarian Cancer
The Adnexal Mass and Early Ovarian Cancer Fred Ueland, MD University of Kentucky Gynecologic Oncology Never give in. Never give in. Never, never, never, never- in nothing great or small, large or petty-
More information